---
title: "Infectious Diseases"
canonical: "https://www.pharmalegacy.com/indications/infectious-diseases/"
lastmod: "2026-07-02T22:14:59+00:00"
generator: "llm-mirrors/1.0.19"
---

Infectious diseases have shaped the course of human history, toppling empires, redefining borders, and uniting scientists in the fight against global pandemics. From ancient plagues to modern outbreaks, their impact is as far-reaching as it is devastating. Despite medical advancements, infectious diseases remain a leading cause of mortality worldwide, claiming over 13 million lives annually (WHO, 2023). But every great challenge inspires innovation. Today, the fight against infectious diseases demands cutting-edge research, robust models, and relentless determination to stay ahead of evolving threats. That’s where PharmaLegacy steps in.
Our mission is to empower antimicrobial drug discovery innovation through End-to-End solutions which cover in vitro activity screenings, IND-enabling studies and more.
PharmaLegacy’s infectious disease models are designed to accelerate your research, delivering actionable insights such as Minimum Inhibitory Concentration (MIC) with precision and reliability. Whether you’re studying bacterial, viral, or fungal pathogens, our models provide robust, translatable data to help you make informed decisions faster.
When you choose PharmaLegacy, you’re partnering with a team that combines deep scientific expertise, BSL2 / BSL3 animal facilities, advanced bioanalytical technologies, and a commitment to excellence. From preclinical evaluations to custom-tailored studies, we ensure your project is executed efficiently, on budget, and with the rigor needed to meet your milestones.